派博傳思國際中心

標(biāo)題: Titlebook: Cancer Active Immunotherapy; Immunoprophylaxis an Georges Mathé Book 1976 Springer-Verlag Berlin · Heidelberg 1976 cancer.cell.immunotherap [打印本頁]

作者: Suture    時間: 2025-3-21 16:52
書目名稱Cancer Active Immunotherapy影響因子(影響力)




書目名稱Cancer Active Immunotherapy影響因子(影響力)學(xué)科排名




書目名稱Cancer Active Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Cancer Active Immunotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Active Immunotherapy被引頻次




書目名稱Cancer Active Immunotherapy被引頻次學(xué)科排名




書目名稱Cancer Active Immunotherapy年度引用




書目名稱Cancer Active Immunotherapy年度引用學(xué)科排名




書目名稱Cancer Active Immunotherapy讀者反饋




書目名稱Cancer Active Immunotherapy讀者反饋學(xué)科排名





作者: 離開可分裂    時間: 2025-3-21 22:57

作者: 不利    時間: 2025-3-22 03:25
M. Gerlach,Jürgen Deckert,E. KoutsilieriTHE .., 1969), it was tempting, in the case of a perceptible tumour, to inject BCG or another adjuvant into the neoplasia. This was tried on human tumours by MORTON .. (1970a, 1970b), and on experimental models by ZBAR, RAPP and co-workers (ZBAR and TANAKA, 1971; ZBAR, 1972; ZBAR .., 1972; RAPP, 1973; ZBAR .., 1973).
作者: 整潔漂亮    時間: 2025-3-22 05:13

作者: Bph773    時間: 2025-3-22 10:42

作者: 玩笑    時間: 2025-3-22 14:27

作者: 玩笑    時間: 2025-3-22 21:05
https://doi.org/10.1007/978-88-470-0706-2 site(s) distant from the primary one, and possibly recurring a long time after primary treatment. The fact that these metastases were not detectable before and after treatment means that surgeons and radiotherapists often leave a few malignant cells in a patient who has been locally well treated. S
作者: 不成比例    時間: 2025-3-22 23:56
https://doi.org/10.1007/978-3-211-73574-9 immune balance was not known. Nevertheless, it appeared reasonable to conduct experiments on active immunotherapy of experimental established tumours, and to apply them to man in the conditions and modalities which were efficient in animals. Later, the knowledge of this plate made the respect of th
作者: 原告    時間: 2025-3-23 04:42
M. Gerlach,Jürgen Deckert,E. KoutsilieriTHE .., 1969), it was tempting, in the case of a perceptible tumour, to inject BCG or another adjuvant into the neoplasia. This was tried on human tumours by MORTON .. (1970a, 1970b), and on experimental models by ZBAR, RAPP and co-workers (ZBAR and TANAKA, 1971; ZBAR, 1972; ZBAR .., 1972; RAPP, 197
作者: seduce    時間: 2025-3-23 08:31

作者: 單色    時間: 2025-3-23 12:58
Depression and Anxiety in Stroketedly explore their immune functions. ABLIN .. (pers. comm.) proposed submitting all patients to an “immunostaging” and he defined rather naive immunostages” based on too simple and too complicated parameters (Table 11.I). Thus if it is too early to classify the immune status of cancer patients into
作者: barium-study    時間: 2025-3-23 14:57
Robertas Bunevi?ius,Arthur J. Prange JrOnly a brief summary will be given of the present concepts concerning these subjects.
作者: endarterectomy    時間: 2025-3-23 21:12

作者: Wallow    時間: 2025-3-24 00:39
Emotions and Multiple SclerosisImmunotherapy most often works by helping the organism to kill the last cell of residual disease, which still remains after other forms of treatment; alternatively, if the preliminary data on the use of immunotherapy in the treatment of perceptible tumours is confirmed, the aim is to assist the treatment in the destruction of more cells.
作者: hyperuricemia    時間: 2025-3-24 04:59

作者: Regurgitation    時間: 2025-3-24 10:18

作者: 雕鏤    時間: 2025-3-24 13:56
James W. Jefferson,John R. MarshallApparently well-endowed with the data and concepts I have described, the medical oncologist is, in fact, still very poor in operational knowledge concerning the clinical use of active systemic immunotherapy, immunorestoration, local immunotherapy, and immunoprophylaxis.
作者: 珊瑚    時間: 2025-3-24 18:19

作者: 四溢    時間: 2025-3-24 22:25
Towards Immunoprophylaxis,It goes without saying that immunoprophylaxis of cancer, when it is no longer a risk, will be much more important than immunotherapy.
作者: 拍下盜公款    時間: 2025-3-24 23:35

作者: persistence    時間: 2025-3-25 03:30
Developmental Pharmacology,Many experiments and some clinical trials have been conducted on specific stimulation for immunotherapy as well as for immunoprevention.
作者: Additive    時間: 2025-3-25 10:09

作者: 撕裂皮肉    時間: 2025-3-25 12:28
Conclusion: Immunotherapy and Immunorestoration Today in the Strategy of Cancer Treatment; Their PeApparently well-endowed with the data and concepts I have described, the medical oncologist is, in fact, still very poor in operational knowledge concerning the clinical use of active systemic immunotherapy, immunorestoration, local immunotherapy, and immunoprophylaxis.
作者: Mri485    時間: 2025-3-25 17:40
Recent Results in Cancer Researchhttp://image.papertrans.cn/c/image/221041.jpg
作者: 表主動    時間: 2025-3-25 21:03

作者: HACK    時間: 2025-3-26 00:19
Cancer Local Active Immunotherapy,THE .., 1969), it was tempting, in the case of a perceptible tumour, to inject BCG or another adjuvant into the neoplasia. This was tried on human tumours by MORTON .. (1970a, 1970b), and on experimental models by ZBAR, RAPP and co-workers (ZBAR and TANAKA, 1971; ZBAR, 1972; ZBAR .., 1972; RAPP, 1973; ZBAR .., 1973).
作者: chiropractor    時間: 2025-3-26 06:38
Toxicology and Adverse Effects, sought can be obtained (tumour growth enhancement). Direct toxic effects, minor or severe and possibly lethal, have been observed. Thus the toxicology (MATHE, 1976; SCHWARZENBERG .., 1976) of this new weapon in cancer treatment must be known.
作者: Integrate    時間: 2025-3-26 08:54
Introduction and Definitions, site(s) distant from the primary one, and possibly recurring a long time after primary treatment. The fact that these metastases were not detectable before and after treatment means that surgeons and radiotherapists often leave a few malignant cells in a patient who has been locally well treated. S
作者: 修飾語    時間: 2025-3-26 16:10
Systemic Active Immunotherapy, immune balance was not known. Nevertheless, it appeared reasonable to conduct experiments on active immunotherapy of experimental established tumours, and to apply them to man in the conditions and modalities which were efficient in animals. Later, the knowledge of this plate made the respect of th
作者: 媽媽不開心    時間: 2025-3-26 17:44
Cancer Local Active Immunotherapy,THE .., 1969), it was tempting, in the case of a perceptible tumour, to inject BCG or another adjuvant into the neoplasia. This was tried on human tumours by MORTON .. (1970a, 1970b), and on experimental models by ZBAR, RAPP and co-workers (ZBAR and TANAKA, 1971; ZBAR, 1972; ZBAR .., 1972; RAPP, 197
作者: 思想流動    時間: 2025-3-27 00:21
Toxicology and Adverse Effects, sought can be obtained (tumour growth enhancement). Direct toxic effects, minor or severe and possibly lethal, have been observed. Thus the toxicology (MATHE, 1976; SCHWARZENBERG .., 1976) of this new weapon in cancer treatment must be known.
作者: 全能    時間: 2025-3-27 03:59

作者: 漂亮    時間: 2025-3-27 09:15
0080-0015 ll Mediated Immunity 19 2. 2. 2. T- and B-Lymphocyte and Monocyte Differen- tiation 22 2. 2. 3. T-Lymphocyte Functions 25 2. 2. 4. B-Lymphocyte Functions 30 2. 978-3-642-81019-0978-3-642-81017-6Series ISSN 0080-0015 Series E-ISSN 2197-6767
作者: Liability    時間: 2025-3-27 13:24

作者: 離開真充足    時間: 2025-3-27 14:19

作者: CUB    時間: 2025-3-27 18:00

作者: EXULT    時間: 2025-3-27 22:41

作者: maverick    時間: 2025-3-28 03:23

作者: Fibrinogen    時間: 2025-3-28 08:41
Introduction and Definitions,ystematic complementary chemotherapy in such cases has recently been claimed to be an excellent means of preventing relapses (E.O.R.T.C., Radiochemoth. Group, 1972; JAFFE ..,1974; BERLIN, 1974). However, it has, in the past,been generally disappointing (MATHE and KENIS, 1975).
作者: transdermal    時間: 2025-3-28 11:28

作者: 漸強    時間: 2025-3-28 14:44
9樓
作者: 捐助    時間: 2025-3-28 22:20
9樓
作者: paragon    時間: 2025-3-29 01:12
9樓
作者: 松雞    時間: 2025-3-29 05:59
10樓
作者: Exposition    時間: 2025-3-29 07:13
10樓
作者: 四指套    時間: 2025-3-29 13:04
10樓
作者: progestogen    時間: 2025-3-29 18:29
10樓




歡迎光臨 派博傳思國際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
新昌县| 平乡县| 象州县| 垦利县| 蕲春县| 蒲江县| 通道| 瓮安县| 辽阳市| 临海市| 苍南县| 黔东| 南平市| 炎陵县| 天峻县| 绿春县| 古丈县| 兰考县| 龙江县| 合作市| 沙洋县| 阿城市| 青河县| 蒙山县| 瓦房店市| 开原市| 渝中区| 县级市| 汾阳市| 诸城市| 崇文区| 利辛县| 阿勒泰市| 甘肃省| 肇州县| 京山县| 海南省| 贞丰县| 吉木乃县| 霍林郭勒市| 行唐县|